{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:33:49Z","timestamp":1790804029488,"version":"4.1.0"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaut.2020.102590","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:39:16Z","timestamp":1607647156000},"page":"102590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Early diagnosis and treatment for Sj\u00f6gren's syndrome: current challenges, redefined disease stages and future prospects"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-8289","authenticated-orcid":false,"given":"Bin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiu","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2020.102590_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary sjogren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sjogren's syndrome","volume":"9","author":"Mavragani","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jaut.2020.102590_bib3","doi-asserted-by":"crossref","first-page":"1902157","DOI":"10.1183\/13993003.02157-2019","article-title":"Pulmonary arterial hypertension associated with primary Sjogren\u2019s syndrome: a multi-centre cohort study from China","volume":"56","author":"Wang","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2020.102590_bib4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10067-018-3987-4","article-title":"Unexplained cough: it is time to rule out Sjogren's syndrome","volume":"37","author":"Koslow","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000789","article-title":"Sjogren's syndrome: state of the art on clinical practice guidelines","volume":"4","author":"Romao","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2020.102590_bib6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/1744666X.2019.1649596","article-title":"Predicting lymphoma development in patients with Sjogren's syndrome","volume":"15","author":"De Vita","year":"2019","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2020.102590_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.autrev.2018.12.008","article-title":"The pipeline of targeted therapies under clinical development for primary Sjogren's syndrome: a systematic review of trials","volume":"18","author":"Felten","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102590_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sjogren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary Sjogren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/BOR.0000000000000473","article-title":"Current views on the pathogenesis of Sjogren's syndrome","volume":"30","author":"Pontarini","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"126","key":"10.1016\/j.jaut.2020.102590_bib13","first-page":"3","article-title":"One year in review 2020: pathogenesis of primary Sjogren's syndrome","volume":"38","author":"Bombardieri","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib14","doi-asserted-by":"crossref","first-page":"102485","DOI":"10.1016\/j.jaut.2020.102485","article-title":"Alteration of CD226\/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjogren's syndrome","volume":"113","author":"Deng","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102590_bib15","series-title":"B Cells in Sjogren's Syndrome: from Pathophysiology to Therapeutic Target. Rheumatology (Oxford)","author":"Mielle","year":"2019"},{"key":"10.1016\/j.jaut.2020.102590_bib16","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3389\/fimmu.2019.02096","article-title":"Plasmacytoid DCs from patients with sjogren's syndrome are transcriptionally primed for enhanced pro-inflammatory cytokine production","volume":"10","author":"Hillen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib17","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","article-title":"Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjogren's syndrome with ectopic germinal centres and MALT lymphoma","volume":"79","author":"Pontarini","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2013.11.003","article-title":"Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjogren's syndrome","volume":"51","author":"Gong","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102590_bib19","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/annrheumdis-2019-216588","article-title":"Salivary gland epithelial cells from patients with Sjogren\u2019s syndrome induce B-lymphocyte survival and activation","volume":"79","author":"Riviere","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/art.40659","article-title":"Salivary gland stem cells age prematurely in primary sjogren's syndrome","volume":"71","author":"Pringle","year":"2019","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib21","first-page":"102364","article-title":"Sjogren's syndrome: old and new therapeutic targets","author":"Mavragani","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102590_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/art.40083","volume":"69","author":"Tezcan","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00296-017-3691-8","article-title":"Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features","volume":"37","author":"Kabasakal","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2020.102590_bib25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/art.40085","volume":"69","author":"Vitali","year":"2017","journal-title":"Reply. Arthritis Rheumatol"},{"key":"10.1016\/j.jaut.2020.102590_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early diagnosis of primary Sjogren's syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Brito-Zeron","year":"2016","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sjogren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib28","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0140-6736(19)32127-0","article-title":"Changing the landscape for type 1 diabetes: the first step to prevention","volume":"394","author":"Dayan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2020.102590_bib29","doi-asserted-by":"crossref","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto's thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation","author":"Ralli","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102590_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.coms.2013.09.003","article-title":"Salivary gland dysfunction and xerostomia in Sjogren's syndrome","volume":"26","author":"Jensen","year":"2014","journal-title":"Oral Maxillofac. Surg. Clin."},{"key":"10.1016\/j.jaut.2020.102590_bib31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","article-title":"Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjogren Project Consortium","volume":"76","author":"Brito-Zeron","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3899\/jrheum.160932","article-title":"Work disability in newly diagnosed patients with primary sjogren syndrome","volume":"44","author":"Mandl","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib33","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/1756-185X.13641","article-title":"Determinants of diagnosis and disease course in primary Sjogren's syndrome: results from datamining of electronic health records","volume":"22","author":"Sandhya","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaut.2020.102590_bib34","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/art.40513","article-title":"Clinical efficacy and safety of baminercept, a lymphotoxin beta receptor fusion protein, in primary sjogren's syndrome: results from a phase II randomized, double-blind, placebo-controlled trial","volume":"70","author":"St Clair","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001064","article-title":"Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjogren's syndrome","volume":"5","author":"Brito-Zeron","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2020.102590_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s12325-017-0501-3","article-title":"The potential role for early biomarker testing as part of a modern, multidisciplinary approach to sjogren's syndrome diagnosis","volume":"34","author":"Beckman","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib37","first-page":"3252","article-title":"Clinical and prognostic characteristics of 573 cases of primary Sjogren's syndrome","volume":"123","author":"Lin","year":"2010","journal-title":"Chinese Med J"},{"key":"10.1016\/j.jaut.2020.102590_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13293-017-0146-6","article-title":"Long-term follow-up in primary Sjogren's syndrome reveals differences in clinical presentation between female and male patients","volume":"8","author":"Ramirez Sepulveda","year":"2017","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.jaut.2020.102590_bib39","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1001\/jama.2013.278448","article-title":"Autoantibodies present before symptom onset in primary Sjogren syndrome","volume":"310","author":"Jonsson","year":"2013","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jaut.2020.102590_bib40","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1097\/MD.0000000000000667","article-title":"Primary Sjogren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients","volume":"94","author":"Zhao","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jaut.2020.102590_bib41","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1038\/s41598-020-67462-z","article-title":"Prevalence of Sjogren's syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases","volume":"10","author":"Narvaez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2020.102590_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/keh455","article-title":"Prevalence of Sjogren's syndrome in ambulatory patients according to the American-European Consensus Group criteria","volume":"44","author":"Sanchez-Guerrero","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2020.102590_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ICO.0b013e31818d3846","article-title":"Evaluation of patients with dry eye for presence of underlying Sjogren syndrome","volume":"28","author":"Akpek","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jaut.2020.102590_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.6061\/clinics\/2014(03)02","article-title":"Sjogren's syndrome: an underdiagnosed condition in mixed connective tissue disease","volume":"69","author":"Usuba","year":"2014","journal-title":"Clinics"},{"key":"10.1016\/j.jaut.2020.102590_bib45","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/ICO.0000000000001714","article-title":"Prevalence of novel candidate sjogren syndrome autoantibodies in the dry eye assessment and management (DREAM) study","volume":"37","author":"Bunya","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.jaut.2020.102590_bib46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1440-1843.2005.00627.x","article-title":"Potential involvement of subclinical Sjogren's syndrome in various lung diseases","volume":"10","author":"Kurumagawa","year":"2005","journal-title":"Respirology"},{"key":"10.1016\/j.jaut.2020.102590_bib47","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren's syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib48","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.joms.2017.05.021","article-title":"Minor salivary gland biopsy-an important contributor to the diagnosis of sjogren syndrome","volume":"75","author":"Wicheta","year":"2017","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jaut.2020.102590_bib49","first-page":"929","article-title":"Minor salivary gland biopsy and Sjogren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers","volume":"30","author":"Tavoni","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib50","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/keu453","article-title":"Reliability of histopathological salivary gland biopsy assessment in Sjogren's syndrome: a multicentre cohort study","volume":"54","author":"Costa","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2020.102590_bib51","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.joms.2019.01.052","article-title":"Discrepancies in interpretation of the minor salivary gland biopsy in the diagnosis of sjogren syndrome","volume":"77","author":"Wicheta","year":"2019","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jaut.2020.102590_bib52","first-page":"938","article-title":"Change in final diagnosis on second evaluation of labial minor salivary gland biopsies","volume":"29","author":"Vivino","year":"2002","journal-title":"J. Rheumatol."},{"issue":"112","key":"10.1016\/j.jaut.2020.102590_bib53","first-page":"222","article-title":"The role of salivary gland histopathology in primary Sjogren's syndrome: promises and pitfalls","volume":"36","author":"Kroese","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib54","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102590_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2017.03.007","article-title":"Insight into pathogenesis of Sjogren's syndrome: dissection on autoimmune infiltrates and epithelial cells","volume":"182","author":"Goules","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib56","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1034\/j.1600-0714.2001.300705.x","article-title":"Reproducibility of biopsy grade in Sjogren's syndrome","volume":"30","author":"Al-Hashimi","year":"2001","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib57","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/rheumatology\/32.7.578","article-title":"Progression of sialadenitis in Sjogren's syndrome","volume":"32","author":"Jonsson","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/acr.23264","article-title":"Natural history and predictors of progression to sjogren's syndrome among participants of the sjogren's international collaborative clinical alliance registry","volume":"70","author":"Shiboski","year":"2018","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2020.102590_bib59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/rheumatology\/36.9.969","article-title":"Quantitative assessment of salivary gland inflammatory infiltration in primary Sjogren's syndrome: its relationship to different demographic, clinical and serological features of the disorder","volume":"36","author":"Gerli","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib60","first-page":"1515","article-title":"Minor salivary gland biopsies in patients investigated for primary Sjogren's syndrome. A review of 187 patients","volume":"20","author":"Wise","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib61","article-title":"Questions from patients and doctors on negative minor salivary gland biopsy in sjogren syndrome","author":"Panchovska","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib62","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/art.30381","article-title":"Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren's syndrome among 1,726 registry participants","volume":"63","author":"Daniels","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/art.10668","article-title":"Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers","volume":"47","author":"Radfar","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib64","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1601-0825.2006.01278.x","article-title":"Immunoprofile of focal lymphocytic infiltration in minor salivary glands of healthy individuals","volume":"13","author":"Yarom","year":"2007","journal-title":"Oral Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib65","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3899\/jrheum.181443","article-title":"Sjogren syndrome without focal lymphocytic infiltration of the salivary glands","volume":"47","author":"Sharma","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib66","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3899\/jrheum.190743","article-title":"With minor salivary gland biopsy in sjogren syndrome, is a negative result possible?","volume":"47","author":"Monsalve","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0961203314554251","article-title":"A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjogren's syndrome","volume":"24","author":"Carubbi","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2020.102590_bib68","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3899\/jrheum.200328","article-title":"Association between glandular infiltrate and leukopenia in sjogren syndrome (SS): data from the Italian research group on SS (GRISS)","volume":"47","author":"Cafaro","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib69","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3899\/jrheum.200350","article-title":"The serological status affects the prognostic role of salivary gland histology in primary sjogren syndrome","volume":"47","author":"Carubbi","year":"2020","journal-title":"J. Rheumatol."},{"issue":"112","key":"10.1016\/j.jaut.2020.102590_bib70","first-page":"102","article-title":"How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project)","volume":"36","author":"Brito-Zeron","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","article-title":"The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome","volume":"10","author":"Hernandez-Molina","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102590_bib72","article-title":"Clinical and serological characteristics of seronegative primary Sjogren\u2019s syndrome: a comparative study","author":"Yazisiz","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib73","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/art.39214","article-title":"Prediction of sjogren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib74","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.autrev.2015.07.002","article-title":"Anti-SSA\/SSB-negative Sjogren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution","volume":"14","author":"Quartuccio","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102590_bib75","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/annrheumdis-2014-206683","article-title":"The SSB-positive\/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren's syndrome","volume":"74","author":"Baer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2018.09.003","article-title":"Novel autoantibodies in Sjogren's syndrome: a comprehensive review","volume":"18","author":"Martin-Nares","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102590_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0714.2004.00264.x","article-title":"Sjogren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation\/xerostomia","volume":"34","author":"Mignogna","year":"2005","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib78","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib79","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib80","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/ard.2007.073825","article-title":"Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors","volume":"67","author":"Jorgensen","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib81","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib82","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib83","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/1529-0131(200103)44:3<647::AID-ANR113>3.0.CO;2-I","article-title":"Long-term outcome of mothers of children with isolated heart block in Finland","volume":"44","author":"Julkunen","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib84","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2008.088054","article-title":"Disease progression in mothers of children enrolled in the research registry for neonatal lupus","volume":"68","author":"Rivera","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib85","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.58.7.423","article-title":"Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both)","volume":"58","author":"Pertovaara","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/art.1780390219","article-title":"Long-term followup of patients with Sjogren's syndrome","volume":"39","author":"Kruize","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib87","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/ar3313","article-title":"Sjogren's syndrome: studying the disease in mice","volume":"13","author":"Delaleu","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib88","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar4362","article-title":"Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue's extracellular milieu precede immune responses in Sjogren's syndrome","volume":"15","author":"Delaleu","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib89","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3389\/fimmu.2018.02362","article-title":"Gene expression profiling of lacrimal glands identifies the ectopic expression of MHC II on glandular cells as a presymptomatic feature in a mouse model of primary sjogren's syndrome","volume":"9","author":"Yin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib90","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/labinvest.3700487","article-title":"Early pathogenic events associated with Sjogren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis","volume":"86","author":"Killedar","year":"2006","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jaut.2020.102590_bib91","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3389\/fimmu.2020.01158","article-title":"Recent advances in mouse models of sjogren's syndrome","volume":"11","author":"Gao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib92","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/154411130201300103","article-title":"Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update","volume":"13","author":"Cha","year":"2002","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib93","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.exer.2008.10.006","article-title":"Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjogren's syndrome (SJS)-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"88","author":"Nguyen","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jaut.2020.102590_bib94","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar2676","article-title":"Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren's syndrome-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"11","author":"Nguyen","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib95","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/art.27362","article-title":"Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure","volume":"62","author":"Ewert","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib96","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.autrev.2015.01.009","article-title":"Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease","volume":"14","author":"Lerner","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102590_bib97","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI98554","article-title":"Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability","volume":"129","author":"Nalle","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2020.102590_bib98","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2014-206297","article-title":"Interaction between innate immunity and Ro52-induced antibody causes Sjogren's syndrome-like disorder in mice","volume":"75","author":"Szczerba","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231473","article-title":"Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjogren's syndrome","volume":"15","author":"Jirsova","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2020.102590_bib100","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jaci.2016.01.024","article-title":"Cytometry by time-of-flight immunophenotyping identifies a blood Sjogren's signature correlating with disease activity and glandular inflammation","volume":"137","author":"Mingueneau","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib101","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12967-019-2017-x","article-title":"B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-kappaB pathway in primary Sjogren's syndrome","volume":"17","author":"Li","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1529-0131(199902)42:2<229::AID-ANR4>3.0.CO;2-X","article-title":"Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjogren's syndrome","volume":"42","author":"Manoussakis","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cei.13242","article-title":"Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjogren's syndrome patients","volume":"196","author":"Shimizu","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib104","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/art.40182","article-title":"Increased CCL25 and T helper cells expressing CCR9 in the salivary glands of patients with primary sjogren's syndrome: potential new Axis in lymphoid neogenesis","volume":"69","author":"Blokland","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib105","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9","article-title":"Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome","volume":"44","author":"Amft","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib106","first-page":"131","article-title":"Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren's syndrome","volume":"19","author":"Koski","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib107","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/ard.60.5.473","article-title":"Glandular and extraglandular expression of costimulatory molecules in patients with Sjogren's syndrome","volume":"60","author":"Matsumura","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib108","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/rheumatology\/34.4.326","article-title":"Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren's syndrome","volume":"34","author":"Boumba","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib109","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/ard.45.8.677","article-title":"HLA-DR expression by labial minor salivary gland tissues in Sjogren's syndrome","volume":"45","author":"Moutsopoulos","year":"1986","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib110","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar1912","article-title":"B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome","volume":"8","author":"Ittah","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113392","article-title":"Involvement of aquaporins in the pathogenesis, diagnosis and treatment of sjogren's syndrome","volume":"19","author":"Soyfoo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2020.102590_bib112","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2334\/josnusd.17-0150","article-title":"Expression of aquaporin 3 and 5 as a potential marker for distinguishing dry mouth from Sjogren's syndrome","volume":"60","author":"Ichiyama","year":"2018","journal-title":"J. Oral Sci."},{"key":"10.1016\/j.jaut.2020.102590_bib113","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/08916934.2017.1341495","article-title":"Abnormal distribution of AQP4 in minor salivary glands of primary Sjogren's syndrome patients","volume":"50","author":"Sisto","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2020.102590_bib114","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/rheumatology\/kez316","article-title":"Aberrant MUC1 accumulation in salivary glands of Sjogren's syndrome patients is reversed by TUDCA in vitro","volume":"59","author":"Castro","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2020.102590_bib115","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/odi.13098","article-title":"Oral epithelial membrane-associated mucins and transcriptional changes with Sjogren's syndrome","volume":"25","author":"Culp","year":"2019","journal-title":"Oral Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib116","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1074\/mcp.M115.052993","article-title":"Reduced mucin-7 (Muc7) sialylation and altered saliva rheology in sjogren's syndrome associated oral dryness","volume":"15","author":"Chaudhury","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jaut.2020.102590_bib117","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/eji.201948478","article-title":"Manipulation of epithelial integrity and mucosal immunity by host and microbiota-derived metabolites","volume":"50","author":"Kayama","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib118","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jclinpath-2013-201917","article-title":"Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis","volume":"67","author":"Sasaki","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2020.102590_bib119","series-title":"The Role of Stroma and Epithelial Cells in Primary Sjogren's Syndrome. Rheumatology (Oxford)","author":"Asam","year":"2019"},{"key":"10.1016\/j.jaut.2020.102590_bib120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.02.001","article-title":"Sjogren's syndrome and the epithelial target: a comprehensive review","volume":"42","author":"Barrera","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102590_bib121","first-page":"247","article-title":"Salivary gland changes in the NOD mouse model for Sjogren's syndrome: is there a non-immune genetic trigger?","volume":"36","author":"Humphreys-Beher","year":"1998","journal-title":"Eur. J. Morphol."},{"key":"10.1016\/j.jaut.2020.102590_bib122","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1084\/jem.20080174","article-title":"Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy","volume":"205","author":"Ishimaru","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib123","article-title":"Dysregulation of NF-kB in glandular epithelial cells results in Sjogren's-like features","volume":"13","author":"Wang","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2020.102590_bib124","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0022034519837240","article-title":"Targeted TNF-alpha overexpression drives salivary gland inflammation","volume":"98","author":"Limaye","year":"2019","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jaut.2020.102590_bib125","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/rheumatology\/keaa012","article-title":"Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjogren\u2019s syndrome","volume":"59","author":"Wang","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2020.102590_bib126","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/art.11178","article-title":"Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjogren's syndrome patients: correlation with reduced structural integrity of acini and ducts","volume":"48","author":"Goicovich","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib127","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/ard.2004.033837","article-title":"Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration","volume":"65","author":"Molina","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib128","first-page":"785","article-title":"Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjogren's syndrome","volume":"30","author":"Baldini","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.exer.2013.07.015","article-title":"Tears as a source of biomarkers for ocular and systemic diseases","volume":"117","author":"von Thun Und Hohenstein-Blaul","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jaut.2020.102590_bib130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0049-0172(97)80017-0","article-title":"Saliva: an additional diagnostic tool in Sjogren's syndrome","volume":"27","author":"Tishler","year":"1997","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib131","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.rdc.2016.03.004","article-title":"The proteomics of saliva in sjogren's syndrome","volume":"42","author":"Katsiougiannis","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jaut.2020.102590_bib132","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.60.12.1110","article-title":"Sialometry and sialochemistry: diagnostic tools for Sjogren's syndrome","volume":"60","author":"Kalk","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib133","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/acr.20289","article-title":"Preclinical validation of salivary biomarkers for primary Sjogren's syndrome","volume":"62","author":"Hu","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2020.102590_bib134","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/ard.61.2.137","article-title":"Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjogren's syndrome","volume":"61","author":"Kalk","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/1354750X.2018.1514656","article-title":"Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjogren's Syndrome","volume":"24","author":"Janga","year":"2019","journal-title":"Biomarkers"},{"key":"10.1016\/j.jaut.2020.102590_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2017.05.006","article-title":"Degradation of proteoglycan 4\/lubricin by cathepsin S: potential mechanism for diminished ocular surface lubrication in Sjogren's syndrome","volume":"161","author":"Regmi","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jaut.2020.102590_bib137","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00784-019-03165-8","article-title":"Proteomic profile of saliva collected directly from ducts: a systematic review","volume":"24","author":"Esteves","year":"2020","journal-title":"Clin. Oral Invest."},{"key":"10.1016\/j.jaut.2020.102590_bib138","first-page":"21","article-title":"Salivary biomarkers and their application in the diagnosis and monitoring of the most common oral pathologies","author":"Melguizo-Rodriguez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2020.102590_bib139","doi-asserted-by":"crossref","first-page":"103877","DOI":"10.1016\/j.jprot.2020.103877","article-title":"Proteomics of saliva, plasma, and salivary gland tissue in Sjogren's syndrome and non-Sjogren patients identify novel biomarker candidates","volume":"225","author":"Sembler-Moller","year":"2020","journal-title":"J Proteomics"},{"key":"10.1016\/j.jaut.2020.102590_bib140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13075-019-1961-4","article-title":"Proteomic and histopathological characterisation of sicca subjects and primary Sjogren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers","volume":"21","author":"Aqrawi","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib141","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1021\/acs.jproteome.6b01051","article-title":"Alterations in the salivary proteome and N-glycome of sjogren's syndrome patients","volume":"16","author":"Hall","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jaut.2020.102590_bib142","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13075-017-1228-x","article-title":"Identification of potential saliva and tear biomarkers in primary Sjogren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis","volume":"19","author":"Aqrawi","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib143","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/art.39015","article-title":"High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjogren's syndrome","volume":"67","author":"Delaleu","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib144","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1586\/1744666X.2014.922877","article-title":"Presymptomatic autoantibodies in Sjogren's syndrome: what significance do they hold for the clinic?","volume":"10","author":"Henriksson","year":"2014","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib145","doi-asserted-by":"crossref","first-page":"3642937","DOI":"10.1155\/2019\/3642937","article-title":"Tissue-specific autoantibodies improve diagnosis of primary sjogren's syndrome in the early stage and indicate localized salivary injury","volume":"2019","author":"Jin","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaut.2020.102590_bib146","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12886-015-0023-1","article-title":"Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort","volume":"15","author":"Suresh","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102590_bib147","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2014.08.009","article-title":"Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome","volume":"155","author":"Shen","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib148","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/ICO.0000000000001471","article-title":"Utility of novel autoantibodies in the diagnosis of sjogren's syndrome among patients with dry eye","volume":"37","author":"Karakus","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.jaut.2020.102590_bib149","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1874312901711010010","article-title":"Evaluation of autoantibodies in patients with primary and secondary sjogren's syndrome","volume":"11","author":"De Langhe","year":"2017","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.jaut.2020.102590_bib150","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2147\/OPTH.S106973","article-title":"Characterization of the serological biomarkers associated with Sjogren's syndrome in patients with recalcitrant dry eye disease","volume":"10","author":"Matossian","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jaut.2020.102590_bib151","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2017.12.008","article-title":"Investigation of autoantibodies to SP-1 in Chinese patients with primary Sjogren's syndrome","volume":"188","author":"Xuan","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib152","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111863","article-title":"Associations of anti-aquaporin 5 autoantibodies with serologic and histopathological features of sjogren's syndrome","volume":"8","author":"Jeon","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib153","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2741\/4689","article-title":"Autoantibodies against muscarinic acetylcholine receptor M3 in Sjogren's syndrome and corresponding mouse models","volume":"23","author":"Yu","year":"2018","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jaut.2020.102590_bib154","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/rheumatology\/kex328","article-title":"Antibodies to aquaporins are frequent in patients with primary Sjogren's syndrome","volume":"56","author":"Tzartos","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2020.102590_bib155","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12026-016-8786-x","article-title":"Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sjogren's syndrome","volume":"64","author":"Alam","year":"2016","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2020.102590_bib156","article-title":"Autoantibodies against muscarinic type 3 receptor in Sjogren's syndrome inhibit aquaporin 5 trafficking","volume":"8","author":"Lee","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2020.102590_bib157","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1177\/0022034517717965","article-title":"Functional epitopes for anti-aquaporin 5 antibodies in sjogren syndrome","volume":"96","author":"Alam","year":"2017","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jaut.2020.102590_bib158","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.4110\/in.2019.19.e44","article-title":"Autoantibody-mediated dysfunction of salivary glands leads to xerostomia in SKG mice","volume":"19","author":"Choi","year":"2019","journal-title":"Immune Netw"},{"key":"10.1016\/j.jaut.2020.102590_bib159","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/art.40550","article-title":"Brief report: anti-calponin 3 autoantibodies: a newly identified specificity in patients with sjogren's syndrome","volume":"70","author":"Birnbaum","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib160","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/annrheumdis-2015-207751","article-title":"Antibodies against carbamylated proteins are present in primary Sjogren's syndrome and are associated with disease severity","volume":"75","author":"Bergum","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib161","doi-asserted-by":"crossref","first-page":"14306","DOI":"10.18632\/oncotarget.14882","article-title":"Autoantibody to MDM2: a potential serological marker of primary Sjogren's syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2020.102590_bib162","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/art.39497","article-title":"Brief report: patients with primary sjogren's syndrome who are positive for autoantibodies to tripartite motif-containing protein 38 show greater disease severity","volume":"68","author":"Wolska","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib163","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/acr.22632","article-title":"Association of antibodies to interferon-inducible protein-16 with markers of more severe disease in primary sjogren's syndrome","volume":"68","author":"Baer","year":"2016","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2020.102590_bib164","article-title":"Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus","author":"Wang","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcrc.2018.10.028","article-title":"Validation of diagnostic gene sets to identify critically ill patients with sepsis","volume":"49","author":"Maslove","year":"2019","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.jaut.2020.102590_bib166","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1056\/NEJMoa1303657","article-title":"Diagnosis of childhood tuberculosis and host RNA expression in Africa","volume":"370","author":"Anderson","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib167","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2018.2293","article-title":"Diagnosis of kawasaki disease using a minimal whole-blood gene expression signature","volume":"172","author":"Wright","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaut.2020.102590_bib168","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2020.102590_bib169","doi-asserted-by":"crossref","first-page":"100291","DOI":"10.1016\/j.eclinm.2020.100291","article-title":"Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study","volume":"20","author":"Guthridge","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaut.2020.102590_bib170","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1093\/rheumatology\/keaa167","article-title":"Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers","volume":"59","author":"Chasset","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2020.102590_bib171","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sjogren's syndrome","volume":"10","author":"Emamian","year":"2009","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2020.102590_bib172","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3899\/jrheum.100486","article-title":"Activation of the interferon pathway in peripheral blood of patients with Sjogren's syndrome","volume":"38","author":"Kimoto","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib173","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-020-02248-2","article-title":"Identification of novel genes associated with dysregulation of B cells in patients with primary Sjogren's syndrome","volume":"22","author":"Inamo","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2020.102590_bib174","doi-asserted-by":"crossref","first-page":"102439","DOI":"10.1016\/j.jaut.2020.102439","article-title":"Gene expression profiling of epithelium-associated FcRL4(+) B cells in primary Sjogren's syndrome reveals a pathogenic signature","volume":"109","author":"Verstappen","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102590_bib175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/1744666X.2014.876364","article-title":"Type I IFN signature in primary Sjogren's syndrome patients","volume":"10","author":"Brkic","year":"2014","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102590_bib176","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/kez335","article-title":"Unique Sjogren's syndrome patient subsets defined by molecular features","volume":"59","author":"James","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2020.102590_bib177","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102590_bib178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143970","article-title":"A transcriptional signature of fatigue derived from patients with primary sjogren's syndrome","volume":"10","author":"James","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2020.102590_bib179","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","article-title":"Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status","volume":"77","author":"Md Yusof","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib180","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.annonc.2020.05.019","article-title":"Prognostic gene expression signature for high-grade serous ovarian cancer","volume":"31","author":"Millstein","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jaut.2020.102590_bib181","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1111\/cas.14137","article-title":"A qualitative transcriptional signature for the early diagnosis of colorectal cancer","volume":"110","author":"Guan","year":"2019","journal-title":"Canc. Sci."},{"key":"10.1016\/j.jaut.2020.102590_bib182","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1470-2045(10)70295-3","article-title":"Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jaut.2020.102590_bib183","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib184","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dib.2017.12.023","article-title":"Perturbation of transcriptome in non-neoplastic salivary gland epithelial cell lines derived from patients with primary Sjogren's syndrome","volume":"17","author":"Vakrakou","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.jaut.2020.102590_bib185","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4103\/0366-6999.232809","article-title":"A predictive model for estimation risk of proliferative lupus nephritis","volume":"131","author":"Chen","year":"2018","journal-title":"Chinese Med J"},{"key":"10.1016\/j.jaut.2020.102590_bib186","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib187","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib188","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib189","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1136\/annrheumdis-2018-213201","article-title":"Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model","volume":"77","author":"Wu","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2020.102590_bib190","series-title":"How to Treat Sjogren's Syndrome. Rheumatology (Oxford)","author":"Price","year":"2019"},{"key":"10.1016\/j.jaut.2020.102590_bib191","doi-asserted-by":"crossref","first-page":"102316","DOI":"10.1016\/j.jaut.2019.102316","article-title":"Predictive markers of lymphomagenesis in Sjogren's syndrome: from clinical data to molecular stratification","volume":"104","author":"Kapsogeorgou","year":"2019","journal-title":"J. Autoimmun."},{"issue":"112","key":"10.1016\/j.jaut.2020.102590_bib192","first-page":"121","article-title":"Severe, life-threatening phenotype of primary Sjogren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)","volume":"36","author":"Flores-Chavez","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2020.102590_bib193","doi-asserted-by":"crossref","first-page":"105895","DOI":"10.1016\/j.rmed.2020.105895","article-title":"Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjogren syndrome","volume":"163","author":"Buvry","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib194","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid factor and disease activity are independent predictors of lymphoma in primary sjogren's syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2020.102590_bib195","article-title":"Lymphomas complicating primary Sjogren\u2019s syndrome: from autoimmunity to lymphoma","author":"Nocturne","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2020.102590_bib196","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaut.2017.09.007","article-title":"Impaired anti-inflammatory activity of PPARgamma in the salivary epithelia of Sjogren's syndrome patients imposed by intrinsic NF-kappaB activation","volume":"86","author":"Vakrakou","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102590_bib197","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/ro-positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2020.102590_bib198","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1167\/iovs.19-27469","article-title":"The effect of chloroquine on the development of dry eye in sjogren syndrome animal model","volume":"60","author":"Lee","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jaut.2020.102590_bib199","doi-asserted-by":"crossref","first-page":"361ra137","DOI":"10.1126\/scitranslmed.aag0367","article-title":"Autoimmune manifestations in aged mice arise from early-life immune dysregulation","volume":"8","author":"Mahmoud","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2020.102590_bib200","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.molimm.2005.09.003","article-title":"Role of complement and B lymphocytes in Sjogren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice","volume":"43","author":"Nguyen","year":"2006","journal-title":"Mol. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120302250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841120302250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:28:10Z","timestamp":1760257690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841120302250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":200,"alternative-id":["S0896841120302250"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102590","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early diagnosis and treatment for Sj\u00f6gren's syndrome: current challenges, redefined disease stages and future prospects","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102590"}}